These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34144386)

  • 1. Utility of the "2019 ACR/EULAR classification criteria" for the management of patients with IgG4-related disease.
    Della-Torre E; Lanzillotta M; Germanò T; Mancuso G; Ramirez GA; Capurso G; Falconi M; Dagna L
    Semin Arthritis Rheum; 2021 Aug; 51(4):761-765. PubMed ID: 34144386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes.
    Lanzillotta M; Campochiaro C; Mancuso G; Ramirez GA; Capurso G; Falconi M; Dagna L; Della-Torre E
    Rheumatology (Oxford); 2020 Sep; 59(9):2435-2442. PubMed ID: 32591828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The external validation of the 2019 ACR/EULAR classification criteria for IgG4-related disease in a large cohort from China.
    Liu Z; Nie Y; Peng Y; Lu H; Zhang P; Li J; Sun R; Li J; Sun B; He X; Zhou J; Fei Y; Peng L; Zhang W; Zeng X
    Semin Arthritis Rheum; 2023 Aug; 61():152202. PubMed ID: 37167774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics and Classification Criteria Performance in a Single-Center Cohort of 114 Patients With Immunoglobulin G4-Related Disease.
    Spandorfer R; Ahmad M; Khosroshahi A
    J Clin Rheumatol; 2023 Jan; 29(1):23-28. PubMed ID: 35905474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of
    Bai Z; Zhou T; Yu Z; Chen Y; Dong L
    Ann Nucl Med; 2022 Jul; 36(7):651-660. PubMed ID: 35604531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiology domain in the diagnosis of IgG4-RD according to the 2019 American College of Rheumatology and European League Against Rheumatism classification.
    Elbanna KY; Kowa JY; Mirajkar N; Khalili K; Kim TK
    Insights Imaging; 2024 Mar; 15(1):94. PubMed ID: 38530483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort.
    Vikse J; Midtvedt Ø; Fevang BS; Garen T; Palm Ø; Wallenius M; Bakland G; Norheim KB; Molberg Ø; Hoffmann-Vold AM
    Arthritis Res Ther; 2023 Sep; 25(1):163. PubMed ID: 37670401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [IgG4-related disease: Diagnostic criteria evolution toward the 2019 ACR/EULAR classification criteria].
    Schleinitz N; Briantais A; Ebbo M
    Rev Med Interne; 2020 Dec; 41(12):814-821. PubMed ID: 32732082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG4-related disease: Effectiveness evaluation through Umehara-Okazaki 2011 and ACR/EULAR 2019 diagnostic criteria.
    Martínez Calabuig P; Fragío Gil JJ; González Mazarío R; López Gutiérrez F; Loricera García J; Blanco Alonso R; Campos Fernández C
    Med Clin (Barc); 2024 Sep; 163(5):217-223. PubMed ID: 38849269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and therapeutic response of immunoglobulin G4-related disease: a retrospective study of 127 Chinese patients.
    An W; Wu Z; Li M; Yu H; Zhao X; Wang X; Wang Y; Wang Q; Duan W; Kong Y; Ma H; Ou X; You H; Liu Y; Li P; Duan T; Jia J
    Orphanet J Rare Dis; 2022 Aug; 17(1):307. PubMed ID: 35927746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive disease-specific autoantibodies have limited clinical significance in diagnosing IgG4-related disease in daily clinical practice.
    Mizushima I; Yamano T; Kawahara H; Hibino S; Nishioka R; Zoshima T; Hara S; Ito K; Fujii H; Nomura H; Kawano M
    Rheumatology (Oxford); 2021 Jul; 60(7):3317-3325. PubMed ID: 33313857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of classification and diagnostic criteria for IgG4-related disease and comparison of patients with and without IgG4-related disease.
    Kogami M; Abe Y; Ando T; Makiyama A; Yamaji K; Tamura N
    Sci Rep; 2023 Feb; 13(1):2509. PubMed ID: 36782006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the 2019 ACR/EULAR Classification Criteria for IgG4-Related Disease in a Large Chinese Cohort.
    An ZY; Fu JN; Zeng QZ; Zhufeng YZ; Ning XR; Li HJ; Ma XB; Wang KK; Bian WJ; Zhang YX; Li ZG; Liu YY
    J Clin Rheumatol; 2024 Mar; 30(2):73-78. PubMed ID: 38268091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex as a predictor of clinical phenotype and determinant of immune response in IgG4-related disease: a retrospective study of patients fulfilling the American College of Rheumatology-European League Against Rheumatism classification criteria.
    Jha I; McMahon GA; Perugino CA; Katz G; Wallace ZS; Fernandes A; Jiang B; Zhang Y; McMahon AE; Guy TV; Liu H; Hernandez-Barco YG; Pillai S; Stone JH
    Lancet Rheumatol; 2024 Jul; 6(7):e460-e468. PubMed ID: 38824935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG4-related uveitis. A French cohort and literature review.
    Stuchfield-Denby E; De Sainte Marie B; Hie M; Hatchuel Y; Gerber A; Bencheikh S; Pugnet G; Groh M; Farhat MM; Urbina D; Ebbo M; Schleinitz N
    Semin Arthritis Rheum; 2024 Feb; 64():152278. PubMed ID: 38000318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.
    Wallace ZS; Naden RP; Chari S; Choi H; Della-Torre E; Dicaire JF; Hart PA; Inoue D; Kawano M; Khosroshahi A; Kubota K; Lanzillotta M; Okazaki K; Perugino CA; Sharma A; Saeki T; Sekiguchi H; Schleinitz N; Stone JR; Takahashi N; Umehara H; Webster G; Zen Y; Stone JH;
    Arthritis Rheumatol; 2020 Jan; 72(1):7-19. PubMed ID: 31793250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IgG4-negative IgG4-related disease with a cardiac mass: A case report.
    Namba K; Sakai D; Mikamo H; Sugizaki Y; Sugiura Y; Hiruta N; Matsuzawa Y; Kaneko K
    Medicine (Baltimore); 2023 Aug; 102(31):e34533. PubMed ID: 37543826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG4-related disease administered dupilumab: case series and review of the literature.
    Kanda M; Kamekura R; Sugawara M; Nagahata K; Suzuki C; Takano K; Takahashi H
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 36894196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease.
    Wallace ZS; Naden RP; Chari S; Choi HK; Della-Torre E; Dicaire JF; Hart PA; Inoue D; Kawano M; Khosroshahi A; Lanzillotta M; Okazaki K; Perugino CA; Sharma A; Saeki T; Schleinitz N; Takahashi N; Umehara H; Zen Y; Stone JH;
    Ann Rheum Dis; 2020 Jan; 79(1):77-87. PubMed ID: 31796497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry in IgG4-related disease diagnosis.
    Onwuka DC; Chen LYC; Zhan SH; Seidman MA; Cartagena L; Killow V; Abou-Tak H; Mattman A; Carruthers MN
    Sci Rep; 2024 Jan; 14(1):2584. PubMed ID: 38297074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.